Acceleron Pharma reported $718.15M in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Akebia Therapeutics AKBA:US $ 137.15M 37.48M
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
Amgen AMGN:US $ 8217M 30M
Arena Pharmaceuticals ARNA:US $ 800.72M 170.36M
Bayer BAYN:GR € 31103M 714M
Biomarin Pharmaceutical BMRN:US $ 4266.15M 24.58M
Bluebird Bio BLUE:US $ 870.53M 114.03M
Clovis Oncology CLVS:US $ -225.46M 18.48M
Dicerna Pharmaceuticals DRNA:US $ 107.66M 3.41M
Eli Lilly And LLY:US $ 7757M 1312.6M
Exelixis EXEL:US $ 2112.45M 69.37M
Gilead Sciences GILD:US $ 21471M 1768M
GlaxoSmithKline GSK:LN 15426M 49M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Mirati Therapeutics MRTX:US $ 1084.03M 44.9M
Neurocrine Biosciences NBIX:US $ 1346M 66.8M
Novartis NOVN:VX SF 56771M 2729M
Ptc Therapeutics PTCT:US $ 104.93M 91.65M
Puma Biotechnology PBYI:US $ -10.92M 40.39M
Regeneron Pharmaceuticals REGN:US $ 17258M 2130.7M
Rigel Pharmaceuticals RIGL:US $ 49.67M 18.44M
Sangamo Biosciences SGMO:US $ 406.02M 39.44M
Tg Therapeutics TGTX:US $ 311.52M 71.61M
Ultragenyx Pharmaceutical RARE:US $ 933.67M 38.5M
United Therapeutics UTHR:US $ 3829.7M 190.2M
Vertex Pharmaceuticals VRTX:US $ 9530.71M 334.31M